Category : Search result: Cipla earnings


Cipla Shares Fall 4% After Q2 Results

Cipla's stock faced significant pressure after Q2 FY2025 results revealed margin pressures despite revenue growth. Discover the key factors behind the 4% decline and what analysts are saying about the pharmaceutical giant's future prospects.

Google's AI Boom Fuels Record $102B Q3 Revenue

Alphabet's Q3 2024 earnings smash expectations as artificial intelligence drives unprecedented growth across Google's advertising and cloud divisions, marking a stunning tech comeback.

Meta Profits Crash 52% on $16B Trump Tax Charge

Meta Platforms reports staggering 52% profit decline in Q3 earnings, hit by massive $16 billion legal charge from Trump administration legislation. Revenue growth continues despite Reality Labs losses.

India's Stock Market Rally: Strong Beyond AI Hype

Discover how robust economic indicators and corporate earnings are fueling India's sustained market growth beyond the artificial intelligence frenzy. Expert analysis reveals why this rally has staying power.

FSSAI's ORS Rules: Cipla Prolyte is Asli ORS

Cipla Health welcomes FSSAI's stringent ORS labelling regulations, positioning Prolyte ORS as the authentic electrolyte solution for dehydration management in India.

SAIL Q2 Results 2025: Date Announced for Earnings

Steel Authority of India Limited (SAIL) has officially announced the date for revealing its Q2 FY2025 financial results. Discover when investors can expect the earnings report and what analysts are predicting for the state-owned metal giant.

EPACK Prefab Soars 15% in Post-Earnings Rally

EPACK Prefab Technologies continues its spectacular run with another 15% surge as investor enthusiasm builds following strong quarterly results. Discover what's driving this remarkable performance.

Colgate, Hero MotoCorp, Kaynes Tech: Stocks to Watch Oct 24

Indian markets brace for action as Colgate Palmolive, Hero MotoCorp, Kaynes Technology and other major players announce quarterly results. Get insights on earnings, board meetings, and stock-specific triggers that could drive market movement.

India Inc Q2 Revenue Grows 6%: CRISIL Report

CRISIL report reveals India's corporate sector shows 6% revenue growth in Q2 FY24, but IT services and steel sectors face significant slowdown. Discover which industries are driving growth.

Eli Lilly-Cipla Partner for Weight Loss Drugs in India

Pharma giant Eli Lilly collaborates with Indian partner Cipla to introduce groundbreaking obesity and diabetes treatments Mounjaro and Yurpeak in the Indian market, expanding access to innovative weight management solutions.

HUL Q2: GST Impact & Rural Demand Recovery

Hindustan Unilever reports strong Q2 performance with 3.6% revenue growth despite GST challenges. Rural markets show promising recovery signs while urban demand remains steady.

Page 1 of 4